Literature DB >> 11390470

Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.

D Jevremovic1, D D Billadeau, R A Schoon, C J Dick, P J Leibson.   

Abstract

Stimulation of lymphocytes through multichain immune recognition receptors activates multiple signaling pathways. Adaptor proteins play an important role in integrating these pathways by their ability to simultaneously bind multiple signaling components. Recently, the 3BP2 adaptor protein has been shown to positively regulate the transcriptional activity of T cells. However, the mechanisms by which signaling components are involved in this regulation remain unclear, as does a potential role for 3BP2 in the regulation of other cellular functions. Here we describe a positive regulatory role for 3BP2 in NK cell-mediated cytotoxicity. We also identify p95(vav) and phospholipase C-gamma isoforms as binding partners of 3BP2. Our results show that tyrosine-183 of 3BP2 is specifically involved in this interaction and that this residue critically influences 3BP2-dependent function. Therefore, 3BP2 regulates NK cell-mediated cytotoxicity by mobilizing key downstream signaling effectors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390470     DOI: 10.4049/jimmunol.166.12.7219

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  3BP2 deficiency impairs the response of B cells, but not T cells, to antigen receptor ligation.

Authors:  Miguel A de la Fuente; Lalit Kumar; Bao Lu; Raif S Geha
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

Review 2.  RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2011-09-10       Impact factor: 15.470

3.  3BP2 adapter protein is required for receptor activator of NFκB ligand (RANKL)-induced osteoclast differentiation of RAW264.7 cells.

Authors:  Amel GuezGuez; Virginie Prod'homme; Xavier Mouska; Alice Baudot; Claudine Blin-Wakkach; Robert Rottapel; Marcel Deckert
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

4.  Alveolar Bone Protection by Targeting the SH3BP2-SYK Axis in Osteoclasts.

Authors:  Mizuho Kittaka; Tetsuya Yoshimoto; Collin Schlosser; Robert Rottapel; Mikihito Kajiya; Hidemi Kurihara; Ernst J Reichenberger; Yasuyoshi Ueki
Journal:  J Bone Miner Res       Date:  2019-10-24       Impact factor: 6.741

5.  Role of protein kinase C in TBT-induced inhibition of lytic function and MAPK activation in human natural killer cells.

Authors:  Abraham B Abraha; Krupa Rana; Margaret M Whalen
Journal:  Arch Environ Contam Toxicol       Date:  2010-11       Impact factor: 2.804

6.  The adaptor 3BP2 is required for KIT receptor expression and human mast cell survival.

Authors:  Erola Ainsua-Enrich; Eva Serrano-Candelas; Damiana Álvarez-Errico; César Picado; Joan Sayós; Juan Rivera; Margarita Martín
Journal:  J Immunol       Date:  2015-03-25       Impact factor: 5.422

7.  Two closely spaced tyrosines regulate NFAT signaling in B cells via Syk association with Vav.

Authors:  Chih-Hong Chen; Victoria A Martin; Nina M Gorenstein; Robert L Geahlen; Carol Beth Post
Journal:  Mol Cell Biol       Date:  2011-05-23       Impact factor: 4.272

8.  Differential recognition of syk-binding sites by each of the two phosphotyrosine-binding pockets of the Vav SH2 domain.

Authors:  Chih-Hong Chen; Dan Piraner; Nina M Gorenstein; Robert L Geahlen; Carol Beth Post
Journal:  Biopolymers       Date:  2013-11       Impact factor: 2.505

9.  The adaptor 3BP2 is required for early and late events in FcεRI signaling in human mast cells.

Authors:  Erola Ainsua-Enrich; Damiana Alvarez-Errico; Alasdair M Gilfillan; César Picado; Joan Sayós; Juan Rivera; Margarita Martín
Journal:  J Immunol       Date:  2012-08-15       Impact factor: 5.422

10.  Clinicopathologic and Molecular Characteristics of Familial Cherubism with Associated Odontogenic Tumorous Proliferations.

Authors:  Prokopios P Argyris; Rajaram Gopalakrishnan; Ying Hu; Ernst J Reichenberger; Ioannis G Koutlas
Journal:  Head Neck Pathol       Date:  2017-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.